The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 2
  • 1
    Mr Rob Oorthuizen
    Born in June 1972
    Individual (1 offspring)
    Person with significant control
    2016-04-06 ~ now
    PE - Ownership of shares – 75% or moreCIF 0
    PE - Ownership of voting rights - 75% or moreCIF 0
    PE - Right to appoint or remove directorsCIF 0
  • 2
    Beth, Deirdre Michelle
    Director born in May 1952
    Individual (10 offsprings)
    Officer
    2014-10-23 ~ now
    OF - Director → CIF 0
parent relation
Company in focus

OTE PHARMA UK LIMITED

Standard Industrial Classification
46900 - Non-specialised Wholesale Trade
Brief company account
Par Value of Share
Class 1 ordinary share
12023-01-01 ~ 2023-12-31
Property, Plant & Equipment
1,200 GBP2023-12-31
Total Inventories
387,322 GBP2023-12-31
205,633 GBP2022-12-31
Debtors
935,102 GBP2023-12-31
476,366 GBP2022-12-31
Cash at bank and in hand
138,539 GBP2023-12-31
240,185 GBP2022-12-31
Current Assets
1,460,963 GBP2023-12-31
922,184 GBP2022-12-31
Net Current Assets/Liabilities
1,232,325 GBP2023-12-31
554,220 GBP2022-12-31
Total Assets Less Current Liabilities
1,233,525 GBP2023-12-31
554,220 GBP2022-12-31
Equity
Called up share capital
100 GBP2023-12-31
100 GBP2022-12-31
Retained earnings (accumulated losses)
1,233,425 GBP2023-12-31
554,120 GBP2022-12-31
Equity
1,233,525 GBP2023-12-31
554,220 GBP2022-12-31
Average Number of Employees
12023-01-01 ~ 2023-12-31
12022-01-01 ~ 2022-12-31
Property, Plant & Equipment - Gross Cost
Plant and equipment
1,200 GBP2023-12-31
Property, Plant & Equipment
Plant and equipment
1,200 GBP2023-12-31
Trade Debtors/Trade Receivables
Current, Amounts falling due within one year
929,183 GBP2023-12-31
470,447 GBP2022-12-31
Other Debtors
Current, Amounts falling due within one year
5,919 GBP2023-12-31
5,919 GBP2022-12-31
Debtors
Current, Amounts falling due within one year
935,102 GBP2023-12-31
476,366 GBP2022-12-31
Trade Creditors/Trade Payables
Current
27,744 GBP2023-12-31
36,565 GBP2022-12-31
Amounts owed to group undertakings
Current
100,535 GBP2022-12-31
Other Taxation & Social Security Payable
Current
191,645 GBP2023-12-31
222,615 GBP2022-12-31
Other Creditors
Current
9,249 GBP2023-12-31
8,249 GBP2022-12-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
100 shares2023-12-31
Profit/Loss
Retained earnings (accumulated losses)
679,305 GBP2023-01-01 ~ 2023-12-31

  • OTE PHARMA UK LIMITED
    Info
    Registered number 09278402
    C/o Parker Cavendish, Suite 301, Stanmore Business And Innovation Centre, Howard Road, Stanmore, Middlesex HA7 1FW
    Private Limited Company incorporated on 2014-10-23 (10 years 8 months). The company status is Active.
    The last date of confirmation statement was made at 2024-10-23
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.